Session 12: Patient Experience and CLL in Resource Limited Countries

Co-Chair(s)

• 

  Anna Schuh, MD, PhD

  Professor
  Churchill Hospital, Oxford University
  Oxford, England, United Kingdom
• RG

  Raúl Gabus, MD

  Former Head of Hematology and SCT Department
  Hospital Maciel, ASSE
  Montevideo, Montevideo, Uruguay

Presentations:

• 12:50 - 13:00 CEST

  Clinicopathological Features and Treatment Outcomes of Chronic Lymphocytic Leukemia in Pakistan: A Real-World Analysis
  

  Primary Author: Raheel Iftikhar, MBBS, FCPS, FRCP, FACP – National University of Medical Sciences, Rawalpindi, Pakistan

  Co-Author / Presenter: Tanya Siddiqi, MD – City of Hope National Medical Center
• 13:00 - 13:13 CEST

  Development of Resource Restricted Guidelines
  

  Speaker: Mazyar Shadman, MD, MPH – Fred Hutchinson Cancer Center
• 13:13 - 13:26 CEST

  Solutions for Data-Based Research on CLL
  

  Speaker: Kostas Stamatopoulos, MD, PhD – Institute of Applied Biosciences, Centre for Research and Technology Hellas
• 13:26 - 13:39 CEST

  Access to Medicine Update and Patient Experience in LMICs
  

  Speaker: Catherina Scheepers, MS – The Max Foundation

  Speaker: Andrielle Yost, MPA – The Max Foundation
• 13:39 - 13:52 CEST

  Patient Experience in Brazil
  

  Panelist: Catherine Moura – Brazilian Lymphoma and Leukemia Association (Abrale)

  Panelist: Dina Steagall – Brazilian Lymphoma and Leukemia Association (Abrale)
• 13:52 - 14:05 CEST

  Panel Discussion With Interactivity and Audience Q&A